Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?

BACKGROUND: In absence of contraindication, breast cancer patients of reproductive age can undergo fertility preservation with controlled ovarian stimulation for oocyte/embryo cryopreservation before the administration of potentially gonadotoxic treatments. High hormonal levels induced by ovarian st...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalami, Imane, Labrosse, Julie, Cedrin-Durnerin, Isabelle, Comtet, Marjorie, Vinolas, Claire, Krief, Fabien, Sifer, Christophe, Peigne, Maeliss, Grynberg, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188055/
https://www.ncbi.nlm.nih.gov/pubmed/35690817
http://dx.doi.org/10.1186/s12958-022-00958-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188055/
https://www.ncbi.nlm.nih.gov/pubmed/35690817
http://dx.doi.org/10.1186/s12958-022-00958-7

Ejemplares similares